Policy Brief
⭐ 4.8
Interoperability in Biostatistics for Pharmaceutical Firms: Post-Pandemic Lessons
Abstract
This policy brief investigates “Interoperability in Biostatistics for Pharmaceutical Firms: Post-Pandemic Lessons” using a event study methodology. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.